Our customer is a global Contract Development and Manufacturing Organization (CDMO) headquartered in Munich, specializing in pharmaceutical development and manufacturing, notably liquid and solid forms, for clients in Europe, Japan, and North America. The company stands out by offering an integrated approach covering the entire drug lifecycle: from development and technology transfer to commercial production. It currently operates six industrial plants worldwide, including a key site located close to Lyon, France.
Focus on the Rhône Alpes site, located halfway between Valence and Montélimar, has existed since 1918 and currently employs around 220 staff. The facility was acquired by our customer during group consolidation in 2021. The plant specializes in manufacturing sterile liquids (ampoules), suppositories, viscous products, and narcotics, with cold chain capability for sensitive products.
In 2024, our customer invested nearly 13 million euros in building a new aseptic line for injectable ampoules, boosting the site’s capacity by 35–40 percent. This line produce injectable solutions for hospital use such as painkillers, anticoagulants, and anti-inflammatories. The investment also led to the creation of about forty new jobs. This is currently the group’s second most important site. The site’s digital maturity does not meet the group’s expectations. The current position holder, who joined in November 2022, has not met expectations and the group has decided to part ways with an interim manager before recruiting :
Key Responsabilities :
Required Qualifications :
Soft Skills :
Theme : turnaround recovery on IT.
Activity : Industrial Pharmaceutical.
Duration : 6 months minimum.
Status to be defined : THACT Portage
8 Ter rue Salvador Allende
85000 La Roche-sur-Yon
contact@thact-group.fr
THACT présent au salon SME 2025
les 13 et 14 octobre